Differential antinociceptive effects of L-arginine and 3-morpholinosydoimine.
Chung
Eunhee
E
Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Pullman, WA 99164-6534, USA.
Day
Elisabeth
E
Bieber
Andrew
A
Ohgami
Yusuke
Y
Quock
Raymond M
RM
D000700:Analgesics; D000818:Animals; D001120:Arginine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004399:Dynorphins / Q000494:pharmacology; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D008981:Molsidomine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010147:Pain Measurement / Q000187:drug effects
D000700:Analgesics; D009292:Narcotic Antagonists; D009270:Naloxone; C051844:norbinaltorphimine; C002385:linsidomine; D009271:Naltrexone; D004399:Dynorphins; D001120:Arginine; D008981:Molsidomine